Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy
Weimin Yin, Jiao Chang, Jiuyuan Sun, et al.
Journal of Materials Chemistry B (2022) Vol. 11, Iss. 6, pp. 1171-1190
Closed Access | Times Cited: 19

Showing 19 citing articles:

Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 22
Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine
Yanhong Su, Bing Liu, Binghan Wang, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 19
Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
Jing Cai, Xiaoding Xu, Phei Er Saw
Science China Life Sciences (2023) Vol. 67, Iss. 1, pp. 19-40
Closed Access | Times Cited: 22
Photodynamic Therapy Combined with Ferroptosis Is a Synergistic Antitumor Therapy Strategy
Yun-peng Huang, Xiaoyu Li, Zijian Zhang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5043-5043
Open Access | Times Cited: 20
The role of ferroptosis in metabolic diseases
Ling Xie, Bin Fang, Chun Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119480-119480
Open Access | Times Cited: 18
Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system
Yuhan Fu, Jialin Sun, Yanhong Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature
Valentina Tonelotto, Marcel Costa-García, Eve O’Reilly, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron
Luwen Zhu, Yong‐Zhong Du
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124517-124517
Closed Access | Times Cited: 5
Ferroptosis resistance in cancer: recent advances and future perspectives
Zhang Xing, Xiang Li, Xia Ran, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115933-115933
Closed Access | Times Cited: 11
Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
Guangpeng Gao, Xindi Zhang
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancing the understanding of the role of apoptosis in lung cancer immunotherapy: Global research trends, key themes, and emerging frontiers
Chunjian Zuo, Jie Tian
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Therapeutic application of nanosystems-based metalloptosis for enhanced tumor radiotherapy
Meili Chen, Ling Chen, Kun Mao, et al.
Coordination Chemistry Reviews (2025) Vol. 536, pp. 216666-216666
Closed Access
Nanotechnology-Based Delivery Systems for Enhanced Targeting of Tyrosine Kinase Inhibitors: Exploring Inorganic and Organic Nanoparticles as Targeted Carriers
Yana Gvozdeva
Kinases and Phosphatases (2025) Vol. 3, Iss. 2, pp. 9-9
Open Access
Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs
Jiali Yin, Xinjun Xu, Ying Guo, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology
Zongchao Yu, Zhongcheng Mo, Yuan Qiu, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 15, pp. 2012-2021
Closed Access | Times Cited: 2
Recent advances in polysulfide-based prodrug nanomedicines for cancer therapy
Chao Wang, Wenxia Sui, Wujun Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216138-216138
Closed Access | Times Cited: 2
Recent trends and advances in nanosystems with tyrosine kinase inhibitors for image-guided cancer treatments
Ali Tarighatnia, Behrouz Foroughi‐Nia, Nader D. Nader, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104938-104938
Closed Access | Times Cited: 6
Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy
Weimin Yin, Jiao Chang, Jiuyuan Sun, et al.
Applied Materials Today (2023) Vol. 36, pp. 102047-102047
Closed Access | Times Cited: 2
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma
Wei An, Kai Zhang, Guangbing Li, et al.
Translational Oncology (2024) Vol. 52, pp. 102234-102234
Closed Access
Page 1

Scroll to top